Global Leishmaniasis (Kala-Azar) Therapeutics Pipeline Report 2016 - Review of 11 Companies & Drug Profile Activity - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Leishmaniasis (Kala-Azar), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Leishmaniasis (Kala-Azar) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Leishmaniasis (Kala-Azar) Overview
  3. Therapeutics Development
  4. Pipeline Products for Leishmaniasis (Kala-Azar) - Overview
  5. Pipeline Products for Leishmaniasis (Kala-Azar) - Comparative Analysis
  6. Leishmaniasis (Kala-Azar) - Therapeutics under Development by Companies
  7. Leishmaniasis (Kala-Azar) - Therapeutics under Investigation by Universities/Institutes
  8. Leishmaniasis (Kala-Azar) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Leishmaniasis (Kala-Azar) - Products under Development by Companies
  13. Leishmaniasis (Kala-Azar) - Products under Investigation by Universities/Institutes
  14. Leishmaniasis (Kala-Azar) - Companies Involved in Therapeutics Development
  • Advinus Therapeutics Ltd.
  • Anacor Pharmaceuticals, Inc.
  • BioLingus AG
  • Dafra Pharma International Ltd.
  • iCo Therapeutics Inc.
  • ManRos Therapeutics
  • Matinas BioPharma Holdings, Inc.
  • Mologen AG
  • Nanomerics Ltd
  • Takeda Pharmaceutical Company Limited
  • Zydus Cadila Healthcare Limited

For more information visit http://www.researchandmarkets.com/research/h7rx83/leishmaniasis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases Drugs